Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Ferreri AJM, Sassone M, Angelillo P, Zaja F, Re A, Di Rocco A, Spina M, Fabbri A, Stelitano C, Frezzato M, Volpetti S, Zambello R, Rusconi C, De Lorenzo D, Scarano E, Arcari A, Bertoldero G, Nonis A, Calimeri T, Perrone S, Cecchetti C, Tarantino V, Steffanoni S, Foppoli M, Ciceri F, Ponzoni M. Ferreri AJM, et al. Among authors: perrone s. Hematol Oncol. 2020 Aug;38(3):257-265. doi: 10.1002/hon.2742. Epub 2020 May 5. Hematol Oncol. 2020. PMID: 32356913 Clinical Trial.
Primary mediastinal lymphoma: diagnosis and treatment options.
Martelli M, Di Rocco A, Russo E, Perrone S, Foà R. Martelli M, et al. Among authors: perrone s. Expert Rev Hematol. 2015 Apr;8(2):173-86. doi: 10.1586/17474086.2015.994604. Epub 2014 Dec 24. Expert Rev Hematol. 2015. PMID: 25537750 Review.
Clarithromycin as a "repurposing drug" against MALT lymphoma.
Ferreri AJM, Cecchetti C, Kiesewetter B, Sassone M, Calimeri T, Perrone S, Ponzoni M, Raderer M. Ferreri AJM, et al. Among authors: perrone s. Br J Haematol. 2018 Sep;182(6):913-915. doi: 10.1111/bjh.14878. Epub 2017 Aug 2. Br J Haematol. 2018. PMID: 28771670 Free article. No abstract available.
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
Ferreri AJM, Calimeri T, Conte GM, Cattaneo D, Fallanca F, Ponzoni M, Scarano E, Curnis F, Nonis A, Lopedote P, Citterio G, Politi LS, Foppoli M, Girlanda S, Sassone M, Perrone S, Cecchetti C, Ciceri F, Bordignon C, Corti A, Anzalone N. Ferreri AJM, et al. Among authors: perrone s. Blood. 2019 Jul 18;134(3):252-262. doi: 10.1182/blood.2019000633. Epub 2019 May 22. Blood. 2019. PMID: 31118164 Free article. Clinical Trial.
Hematoma-like primary cutaneous peripheral T-cell lymphoma: a rare clinical presentation.
Mercuri SR, Paolino G, Colombo L, Bearzi P, Bellinzona F, Perrone S, Sassone M, Berti E, Rizzo N. Mercuri SR, et al. Among authors: perrone s. Ital J Dermatol Venerol. 2021 Dec;156(Suppl. 1 to No. 6):91-92. doi: 10.23736/S2784-8671.20.06468-8. Epub 2020 Feb 13. Ital J Dermatol Venerol. 2021. PMID: 32057216 Free article. No abstract available.
Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
Ferreri AJM, Sassone M, Miserocchi E, Govi S, Cecchetti C, Corti ME, Mappa S, Arcaini L, Zaja F, Todeschini G, Mannina D, Calimeri T, Perrone S, Ponzoni M, Modorati G. Ferreri AJM, et al. Among authors: perrone s. Blood Adv. 2020 Mar 24;4(6):1013-1019. doi: 10.1182/bloodadvances.2020001459. Blood Adv. 2020. PMID: 32182364 Free PMC article. Clinical Trial.
Reappraising the timing of transplant for indolent non-Hodgkin lymphomas.
Capria S, Barberi W, Perrone S, Ferretti A, Salaroli A, Annechini G, D'Elia GM, Foà R, Pulsoni A. Capria S, et al. Among authors: perrone s. Expert Rev Hematol. 2016 Oct;9(10):951-64. doi: 10.1080/17474086.2016.1226128. Epub 2016 Aug 31. Expert Rev Hematol. 2016. PMID: 27539362 Review.
392 results